Effectiveness	O
of	O
Supplementary	O
Cognitive	B:C4273841
-	I:C4273841
Behavioral	I:C4273841
Therapy	I:C4273841
for	O
Pharmacotherapy	O
-	O
Resistant	O
Depression	O
:	O
A	O
Randomized	O
Controlled	I:C0206035
Trial	I:C0206035
.	O

Effectiveness	O
of	O
Supplementary	O
Cognitive	O
-	I:C4273841
Behavioral	I:C4273841
Therapy	I:C4273841
for	O
Pharmacotherapy	B:C0013216
-	O
Resistant	O
Depression	O
:	O
A	O
Randomized	O
Controlled	I:C0206035
Trial	I:C0206035
.	O

Effectiveness	O
of	O
Supplementary	O
Cognitive	O
-	I:C4273841
Behavioral	I:C4273841
Therapy	I:C4273841
for	O
Pharmacotherapy	O
-	O
Resistant	O
Depression	B:C0011570
:	O
A	O
Randomized	O
Controlled	I:C0206035
Trial	I:C0206035
.	O

Effectiveness	O
of	O
Supplementary	O
Cognitive	O
-	I:C4273841
Behavioral	I:C4273841
Therapy	I:C4273841
for	O
Pharmacotherapy	O
-	O
Resistant	O
Depression	O
:	O
A	O
Randomized	B:C0206035
Controlled	I:C0206035
Trial	I:C0206035
.	O

Antidepressant	B:C0013227
medication	I:C0013227
is	O
efficacious	O
in	O
the	O
treatment	O
of	O
depression	O
,	O
but	O
not	O
all	O
patients	O
improve	O
with	O
antidepressant	O
medication	I:C0013227
alone	O
.	O

Antidepressant	O
medication	I:C0013227
is	O
efficacious	O
in	O
the	O
treatment	B:C0087111
of	O
depression	O
,	O
but	O
not	O
all	O
patients	O
improve	O
with	O
antidepressant	O
medication	I:C0013227
alone	O
.	O

Antidepressant	O
medication	I:C0013227
is	O
efficacious	O
in	O
the	O
treatment	O
of	O
depression	B:C0011570
,	O
but	O
not	O
all	O
patients	O
improve	O
with	O
antidepressant	O
medication	I:C0013227
alone	O
.	O

Antidepressant	O
medication	I:C0013227
is	O
efficacious	O
in	O
the	O
treatment	O
of	O
depression	O
,	O
but	O
not	O
all	O
patients	O
improve	B:C0184511
with	O
antidepressant	O
medication	I:C0013227
alone	O
.	O

Antidepressant	O
medication	I:C0013227
is	O
efficacious	O
in	O
the	O
treatment	O
of	O
depression	O
,	O
but	O
not	O
all	O
patients	O
improve	O
with	O
antidepressant	B:C0013227
medication	I:C0013227
alone	O
.	O

Despite	O
this	O
treatment	B:C0087111
gap	O
,	O
limited	O
evidence	O
regarding	O
the	O
effectiveness	O
of	O
supplementing	O
psychotherapy	O
for	O
pharmacotherapy	O
-	O
resistant	O
depression	O
is	O
available	O
.	O

Despite	O
this	O
treatment	O
gap	O
,	O
limited	O
evidence	O
regarding	O
the	O
effectiveness	O
of	O
supplementing	O
psychotherapy	B:C0033968
for	O
pharmacotherapy	O
-	O
resistant	O
depression	O
is	O
available	O
.	O

Despite	O
this	O
treatment	O
gap	O
,	O
limited	O
evidence	O
regarding	O
the	O
effectiveness	O
of	O
supplementing	O
psychotherapy	O
for	O
pharmacotherapy	B:C0013216
-	O
resistant	O
depression	O
is	O
available	O
.	O

Despite	O
this	O
treatment	O
gap	O
,	O
limited	O
evidence	O
regarding	O
the	O
effectiveness	O
of	O
supplementing	O
psychotherapy	O
for	O
pharmacotherapy	O
-	O
resistant	O
depression	B:C0011570
is	O
available	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	B:C0150270
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	B:C0087111
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	B:C0087111
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	B:C4273841
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	B:C4273841
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	B:C0013216
-	O
resistant	O
depression	O
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	B:C0011570
seeking	O
psychiatric	O
specialty	I:C0033873
care	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effectiveness	O
of	O
supplementing	O
usual	O
medication	O
management	I:C0150270
(	O
treatment	I:C0087111
as	I:C0087111
usual	I:C0087111
[	O
treatment	O
as	I:C0087111
usual	I:C0087111
]	O
)	O
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
(	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
)	O
in	O
patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
seeking	O
psychiatric	B:C0033873
specialty	I:C0033873
care	O
.	O

A	O
16	O
-	O
week	O
assessor	O
-	O
masked	O
randomized	B:C0206035
controlled	I:C0206035
trial	I:C0206035
with	O
a	O
12	O
-	O
month	O
follow	O
-	O
up	O
was	O
conducted	O
in	O
1	O
university	O
hospital	I:C0020028
and	O
1	O
psychiatric	O
hospital	I:C0020021
from	O
September	O
2008	O
to	O
December	O
2014	O
.	O

A	O
16	O
-	O
week	O
assessor	O
-	O
masked	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
with	O
a	O
12	O
-	O
month	O
follow	O
-	O
up	O
was	O
conducted	O
in	O
1	O
university	B:C0020028
hospital	I:C0020028
and	O
1	O
psychiatric	O
hospital	I:C0020021
from	O
September	O
2008	O
to	O
December	O
2014	O
.	O

A	O
16	O
-	O
week	O
assessor	O
-	O
masked	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
with	O
a	O
12	O
-	O
month	O
follow	O
-	O
up	O
was	O
conducted	O
in	O
1	O
university	O
hospital	I:C0020028
and	O
1	O
psychiatric	B:C0020021
hospital	I:C0020021
from	O
September	O
2008	O
to	O
December	O
2014	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	B:C0013216
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	B:C0011570
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	B:C0013227
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	B:C0282574
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	B:C0282574
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	B:C0087111
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	B:C2063866
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	B:C4273841
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	B:C0087111
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	O
as	I:C0087111
usual	I:C0087111
alone	O
.	O

Outpatients	O
aged	O
20	O
-	O
65	O
years	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
(	O
taking	O
antidepressant	O
medications	I:C0013227
for	O
≥	O
8	O
weeks	O
,	O
17	O
-	O
item	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
[	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
]	O
score	O
≥	O
16	O
,	O
Maudsley	O
Staging	I:C0087111
Method	I:C0087111
for	O
treatment	O
-	I:C2063866
resistant	I:C2063866
depression	I:C2063866
score	O
≥	O
3	O
,	O
and	O
DSM	O
-	O
IV	O
criteria	O
for	O
major	O
depressive	O
disorder	O
)	O
were	O
randomly	O
assigned	O
(	O
1:1	O
)	O
to	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
combined	O
with	O
treatment	O
as	I:C0087111
usual	I:C0087111
or	O
to	O
treatment	B:C0087111
as	I:C0087111
usual	I:C0087111
alone	O
.	O

The	O
primary	O
outcome	O
was	O
the	O
alleviation	O
of	O
depressive	B:C0086132
symptoms	I:C0086132
,	O
as	O
measured	O
by	O
change	O
in	O
the	O
total	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
score	O
from	O
baseline	O
to	O
16	O
weeks	O
;	O
primary	O
analysis	O
was	O
done	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

The	O
primary	O
outcome	O
was	O
the	O
alleviation	O
of	O
depressive	O
symptoms	I:C0086132
,	O
as	O
measured	O
by	O
change	O
in	O
the	O
total	O
GRID	B:C0282574
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
score	O
from	O
baseline	O
to	O
16	O
weeks	O
;	O
primary	O
analysis	O
was	O
done	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

The	O
primary	O
outcome	O
was	O
the	O
alleviation	O
of	O
depressive	O
symptoms	I:C0086132
,	O
as	O
measured	O
by	O
change	O
in	O
the	O
total	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
score	O
from	O
baseline	O
to	O
16	O
weeks	O
;	O
primary	O
analysis	B:C0936012
was	O
done	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

A	O
total	O
of	O
80	O
patients	O
were	O
randomized	B:C0034656
;	O
78	O
(	O
97.5	O
%	O
)	O
were	O
assessed	O
for	O
the	O
primary	O
outcome	O
,	O
and	O
73	O
(	O
91.3	O
%	O
)	O
were	O
followed	O
up	I:C1522577
for	O
12	O
months	O
.	O

A	O
total	O
of	O
80	O
patients	O
were	O
randomized	O
;	O
78	O
(	O
97.5	O
%	O
)	O
were	O
assessed	O
for	O
the	O
primary	O
outcome	O
,	O
and	O
73	O
(	O
91.3	O
%	O
)	O
were	O
followed	B:C1522577
up	I:C1522577
for	O
12	O
months	O
.	O

Supplementary	O
cognitive	B:C4273841
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
significantly	O
alleviated	O
depressive	O
symptoms	I:C0086132
at	O
16	O
weeks	O
,	O
as	O
shown	O
by	O
greater	O
least	O
squares	O
mean	O
changes	O
in	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
scores	O
in	O
the	O
intervention	O
group	I:C2986530
than	O
in	O
the	O
control	O
group	O
(	O
-	O
12.7	O
vs	O
-	O
7.4	O
;	O
difference	O
=	O
-	O
5.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.1	O
to	O
-	O
2.6	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
the	O
treatment	O
effect	O
was	O
maintained	O
for	O
at	O
least	O
12	O
months	O
(	O
-	O
15.4	O
vs	O
-	O
11.0	O
;	O
difference	O
=	O
-	O
4.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
7.2	O
to	O
-	O
1.6	O
;	O
P	O
=	O
.002	O
)	O
.	O

Supplementary	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
significantly	O
alleviated	O
depressive	B:C0086132
symptoms	I:C0086132
at	O
16	O
weeks	O
,	O
as	O
shown	O
by	O
greater	O
least	O
squares	O
mean	O
changes	O
in	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
scores	O
in	O
the	O
intervention	O
group	I:C2986530
than	O
in	O
the	O
control	O
group	O
(	O
-	O
12.7	O
vs	O
-	O
7.4	O
;	O
difference	O
=	O
-	O
5.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.1	O
to	O
-	O
2.6	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
the	O
treatment	O
effect	O
was	O
maintained	O
for	O
at	O
least	O
12	O
months	O
(	O
-	O
15.4	O
vs	O
-	O
11.0	O
;	O
difference	O
=	O
-	O
4.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
7.2	O
to	O
-	O
1.6	O
;	O
P	O
=	O
.002	O
)	O
.	O

Supplementary	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
significantly	O
alleviated	O
depressive	O
symptoms	I:C0086132
at	O
16	O
weeks	O
,	O
as	O
shown	O
by	O
greater	O
least	O
squares	O
mean	O
changes	O
in	O
GRID	B:C0282574
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
scores	O
in	O
the	O
intervention	O
group	I:C2986530
than	O
in	O
the	O
control	O
group	O
(	O
-	O
12.7	O
vs	O
-	O
7.4	O
;	O
difference	O
=	O
-	O
5.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.1	O
to	O
-	O
2.6	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
the	O
treatment	O
effect	O
was	O
maintained	O
for	O
at	O
least	O
12	O
months	O
(	O
-	O
15.4	O
vs	O
-	O
11.0	O
;	O
difference	O
=	O
-	O
4.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
7.2	O
to	O
-	O
1.6	O
;	O
P	O
=	O
.002	O
)	O
.	O

Supplementary	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
significantly	O
alleviated	O
depressive	O
symptoms	I:C0086132
at	O
16	O
weeks	O
,	O
as	O
shown	O
by	O
greater	O
least	O
squares	O
mean	O
changes	O
in	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
scores	O
in	O
the	O
intervention	B:C2986530
group	I:C2986530
than	O
in	O
the	O
control	O
group	O
(	O
-	O
12.7	O
vs	O
-	O
7.4	O
;	O
difference	O
=	O
-	O
5.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.1	O
to	O
-	O
2.6	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
the	O
treatment	O
effect	O
was	O
maintained	O
for	O
at	O
least	O
12	O
months	O
(	O
-	O
15.4	O
vs	O
-	O
11.0	O
;	O
difference	O
=	O
-	O
4.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
7.2	O
to	O
-	O
1.6	O
;	O
P	O
=	O
.002	O
)	O
.	O

Supplementary	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
significantly	O
alleviated	O
depressive	O
symptoms	I:C0086132
at	O
16	O
weeks	O
,	O
as	O
shown	O
by	O
greater	O
least	O
squares	O
mean	O
changes	O
in	O
GRID	O
-	I:C0282574
Hamilton	I:C0282574
Depression	I:C0282574
Rating	I:C0282574
Scale	I:C0282574
scores	O
in	O
the	O
intervention	O
group	I:C2986530
than	O
in	O
the	O
control	O
group	O
(	O
-	O
12.7	O
vs	O
-	O
7.4	O
;	O
difference	O
=	O
-	O
5.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
8.1	O
to	O
-	O
2.6	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
the	O
treatment	B:C0087111
effect	O
was	O
maintained	O
for	O
at	O
least	O
12	O
months	O
(	O
-	O
15.4	O
vs	O
-	O
11.0	O
;	O
difference	O
=	O
-	O
4.4	O
;	O
95	O
%	O
CI	O
,	O
-	O
7.2	O
to	O
-	O
1.6	O
;	O
P	O
=	O
.002	O
)	O
.	O

Patients	O
with	O
pharmacotherapy	B:C0013216
-	O
resistant	O
depression	O
treated	O
in	O
psychiatric	O
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	O
management	I:C0150270
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

Patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	B:C0011570
treated	O
in	O
psychiatric	O
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	O
management	I:C0150270
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

Patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
treated	B:C0087111
in	O
psychiatric	O
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	O
management	I:C0150270
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

Patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
treated	O
in	O
psychiatric	B:C1708333
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	O
management	I:C0150270
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

Patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
treated	O
in	O
psychiatric	O
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	B:C0150270
management	I:C0150270
with	O
cognitive	O
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

Patients	O
with	O
pharmacotherapy	O
-	O
resistant	O
depression	O
treated	O
in	O
psychiatric	O
specialty	I:C1708333
care	I:C1708333
settings	I:C1708333
may	O
benefit	O
from	O
supplementing	O
usual	O
medication	O
management	I:C0150270
with	O
cognitive	B:C4273841
-	I:C4273841
behavioral	I:C4273841
therapy	I:C4273841
.	O

